Abstract
In preparing this presentation on risk-benefit analysis in drug research, I found it exceedingly difficult, as you will experience in the minutes to come, to do really more than to merely repeat the classical statements on this difficult and controversial subject that can be found in the abundant scientific and other literature of the last decades.
“When a man has anything to tell in this world, the difficulty is not to make him tell it, but to prevent him from telling it too often.”
(Bernard Shaw).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Janssen, P. (1988). Risk-Benefit Analysis in Drug Research. In: De Clercq, E., Walker, R.T. (eds) Antiviral Drug Development. NATO ASI Series, vol 143. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7275-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7275-2_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7277-6
Online ISBN: 978-1-4684-7275-2
eBook Packages: Springer Book Archive